Forbius Forbius (also known as Formation Biologics) is a protein engineering company that develops biotherapeutics for the treatment of cancer and fibrotic diseases. | ![]() CytomX Therapeutics CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform. | ![]() Bolt Biotherapeutics Bolt Biotherapeutics is a biotechnology company developing immunotherapeutics for multiple types of cancer. | |
Founding Date | Founding Date 2011 | Founding Date 2008 | Founding Date 2015 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Austin, US HQ Montréal, CA | Locations South San Francisco, US HQ | Locations Redwood City, US HQ |
Employees | Employees 811% decrease | Employees 15815% increase | Employees 5248% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 78 m | Valuation ($) 25.6 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $76.2m (FY, 2025) | Revenue (est.) $7.7m (FY, 2025) |
Net income | Net income N/A | Net income ($17.4m) (FY, 2025) | Net income ($33.4m) (FY, 2025) |
Operating ⚠ | |||
Patents (US) | Patents (US) N/A | Patents (US) 13 (FY, 2016) | Patents (US) 1 (FY, 2020) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 132.4m | Total funding raised $ 177.5m |

CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.
View company
Bolt Biotherapeutics is a biotechnology company developing immunotherapeutics for multiple types of cancer.
View company